Inhibikase Therapeutics所有資訊

Inhibikase Therapeutics | SC 13G：超過5%持股股東披露文件-Fairmount Funds Management LLC(9.9%),Peter Harwin(9.9%)等

10/17 19:01 (美東)

Inhibikase Therapeutics | SC 13G：超過5%持股股東披露文件-Commodore Capital LP(9.99%),Commodore Capital Master LP(9.99%)

10/17 16:06 (美東)

Inhibikase Therapeutics | SC 14F1：董事過半數變動聲明

10/11 13:03 (美東)

Inhibikase Therapeutics | 8-K：重大事件

10/10 17:35 (美東)

Inhibikase Therapeutics | SC 13G：超過5%持股股東披露文件-Point72 Asset Management, L.P.(8.4%),Point72 Capital Advisors, Inc.(8.4%)等

10/10 16:15 (美東)

Inhibikase Therapeutics | 8-K：重大事件

10/09 08:41 (美東)

Inhibikase Therapeutics | 10-Q：2024財年二季報

08/14 16:20 (美東)

Inhibikase Therapeutics | 8-K：重大事件

08/06 06:03 (美東)

Inhibikase Therapeutics | 4：持股變動聲明-董事 GRINT PAUL C

07/18 17:31 (美東)

Inhibikase Therapeutics | 4：持股變動聲明-董事 Dion Gisele

07/18 17:27 (美東)

Inhibikase Therapeutics | 4：持股變動聲明-董事 BERMAN DENNIS N

07/18 17:21 (美東)

Inhibikase Therapeutics | 4：持股變動聲明-董事 Freeman Roy Lester

07/18 17:21 (美東)

Inhibikase Therapeutics | 424B3：募資說明書

06/27 12:58 (美東)

Inhibikase Therapeutics | EFFECT：其他

06/27 06:03 (美東)

Inhibikase Therapeutics | CORRESP：信函

06/24 22:18 (美東)

Inhibikase Therapeutics | UPLOAD：其他

06/21 22:16 (美東)

Inhibikase Therapeutics | DEFA14A：其他

06/21 16:31 (美東)

Inhibikase Therapeutics | DEF 14A：股東委託書決議

06/20 18:07 (美東)

Inhibikase Therapeutics | S-1：證券上市註冊聲明

06/18 17:29 (美東)

Inhibikase Therapeutics | PRE 14A：並購重組委托聲明

06/10 16:24 (美東)